Compare Abbott Laboratories (ABT) vs Ford Motor Company (F) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Ford Motor Company — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Ford Motor Company trades at $13.5 (market cap $54.03B). The key difference: Abbott Laboratories is far larger — about 3.1× Ford Motor Company's market cap, and Ford Motor Company pays the higher dividend (4.42%). Which is the better fit depends on your goals.
| ABT | F | |
|---|---|---|
Market Cap | $166.94B | $54.03B |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $17.44 |
52-Week Low | $82.57 | $10.82 |
Enterprise Value | $193.69B | $183.06B |
Dividend Yield | 2.63% | 4.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Ford Motor Company (F) trades at $13.57, up 1.65% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative net income margin and ROE. Recent developments include a strategic semiconductor supply agreement with Micron and vehicle recalls affecting over 110,000 Mustang models. Operating cash flow remains robust at $21.28 billion for 2025, though net income turned negative at -$8.18 billion.
Ford presents a value opportunity with attractive valuation ratios (P/E 11.84, P/S 0.29) but faces significant execution risks. The stock trades below analyst consensus target of $15.00, offering potential upside, though recent sales declines and profitability concerns warrant caution. Key catalysts include EV strategy execution and truck demand strength, while risks include competitive pressures and operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →
